{"product_id":"pharmacogenomics-social-ethical-and-clinical-dimensions-hardback-9780471227694","title":"Pharmacogenomics; Social, Ethical, and Clinical Dimensions (Hardback) 9780471227694","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003ePharmacogenomics\u003c\/font\u003e\u003cbr\u003e\r\n\u003cfont size=\"5\"\u003eSocial, Ethical, and Clinical Dimensions\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cem\u003e\"This volume presents the ethical, legal and social issues as they interface with pharmacogenomics in a very readable and accessible manner...this is an incredibly valuable guide by thought-leaders in the field.\"\u003cbr\u003e --Edward R. B. McCabe, M.D., Ph.D., David Geffen School of Medicine at UCLA, Los Angeles, California\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eMark A. Rothstein (Edited by), MA Rothstein (Author)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780471227694, Wiley\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 30 January 2003\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e384 pages, Drawings: 15 B\u0026amp;W, 0 Color; Tables: 8 B\u0026amp;W, 0 Color\u003cbr\u003e24.6 x 16.2 x 2.3 cm, 0.653 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cem\u003e\u003cfont size=\"3\"\u003e\"The discussion of societal, legal, economic, and governmental issues go well beyond the sphere of pharmogenomics.\" (\u003ci\u003eAmerican Journal for Medical Genetics\u003c\/i\u003e, September 1, 2005)  \u003cp\u003e\"...indispensable guide...as timely as it can be...an impressive multidisciplinary analysis...a 'must read'...\" (\u003ci\u003eBioethics\u003c\/i\u003e, Vol 18(4), August 2004)\u003c\/p\u003e \u003cp\u003e\"…\u003ci\u003ePharmacogenomics\u003c\/i\u003e is highly recommended for anyone with an interest in the field…. Given this book's uniqueness…libraries at any institution teaching pharmcogenomics should have a copy of this book.” (\u003ci\u003eJournal of Pharmacy Technology\u003c\/i\u003e, Sept\/Oct 2003)\u003c\/p\u003e \u003cp\u003e\"...well written, clear, and informative...a restrained sense of excitement...permeates throughout...clearly...a solid contribution to the discourse.\" (\u003ci\u003eNature Biotechnology\u003c\/i\u003e, May 1, 2003)\u003c\/p\u003e \u003cp\u003e\"...chapters offer fascinating glimpses into fields that may not be familiar to geneticists, genomicists, or clinicians...they will be informative...and provide a reminder that many people outside this field are going to be paying a lot of attention as discoveries...are reported.\" (\u003ci\u003eNew England Journal of Medicine\u003c\/i\u003e, July 24, 2003)\u003c\/p\u003e \u003cp\u003e\"...an excellent summary of aspects of phamacogenomics...a solid reference for those working in the field and a unique textbook for those new to the subject area.\" (\u003ci\u003eClinical Chemistry\u003c\/i\u003e, Vol. 49, No. 9)\u003c\/p\u003e \u003cp\u003e\"...a welcome addition to the growing body of literature...highly recommended for anyone with an interest in the field...should be required reading for anyone conducting pharmacogenomic research and for all clinicians who use pharmacogenomics...\" (\u003ci\u003eJournal of Pharmacy Technology\u003c\/i\u003e, Vol. 19September\/October 2003)\u003c\/p\u003e \u003cp\u003e\"...addresses the ethical, legal, and social implications of the individualized medicine that pharmacogenomics stands to create...\" (\u003ci\u003eGenetic Engineering News\u003c\/i\u003e, Vol 23(14), 2003)\u003c\/p\u003e\u003c\/font\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003eThrough analyses of the complex underlying issues, this interdisciplinary volume frames the agenda for dealing with genetic variation and incorporating pharmacogenomics into health care. The three sections of this book, Research Issues, Clinical Issues, and Social Perspectives  address key elements integral to a comprehensive discussion of this emerging field.  \u003cp\u003e\u003cb\u003eThis groundbreaking text…\u003c\/b\u003e\u003c\/p\u003e \u003cul\u003e \u003cli\u003eExamines new research strategies, methodologies, and ethical and social considerations of pharmacogenomics\u003c\/li\u003e \u003cli\u003eAddresses practical considerations of anticipated changes in education, training, oversight, guidelines and protocols, and continuing education requirements\u003c\/li\u003e \u003cli\u003eProvides analyses of the potential enormous impact of pharmacogenomics, such as in the standard of care and treatment, including perspectives from the fields of anthropology, law, ethics, and economics\u003c\/li\u003e \u003c\/ul\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eForeword (F. Collins).  \u003cp\u003ePreface.\u003c\/p\u003e \u003cp\u003ePART I: INTRODUCTION: SCIENCE AND SOCIETY.\u003c\/p\u003e \u003cp\u003ePublic Attitudes About Pharmacogenomics (M. Rothstein, \u003ci\u003eet al.\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003ePharmacogenomics:  Pharmacology and Toxicology in the Genomics (H. Mohrenweiser).\u003c\/p\u003e \u003cp\u003eThe Implications of Population Genetics for Pharmacogenomics (C. Hanis).\u003c\/p\u003e \u003cp\u003ePART II: RESEARCH AND DEVELOPMENT CHALLENGES AND CONSIDERATIONS.\u003c\/p\u003e \u003cp\u003eGenome Research and Minorities (H. Greely).\u003c\/p\u003e \u003cp\u003eDrug Development Strategies (P. Manasco \u0026amp; T. Arledge).\u003c\/p\u003e \u003cp\u003eDrug Development,  Regulation, and Genetically Guided Therapy Pharmacogenomics (D. Feigal \u0026amp; S. Gutman).\u003c\/p\u003e \u003cp\u003eIntellectual Property and Commercial Aspects of Pharmacogenomics (A. Nunnally,  \u003ci\u003eet al.\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003ePART III: CLINICAL APPLICATIONS.\u003c\/p\u003e \u003cp\u003eIntegration of Pharmacogenomics into Medical Practice (G. Omenn \u0026amp; A. Motulsky).\u003c\/p\u003e \u003cp\u003eClinical Utility Pharmacogenetics and Pharmacogenomics (N. Holtzman).\u003c\/p\u003e \u003cp\u003eMedical Liability for Pharmacogenomics (L. Palmer).\u003c\/p\u003e \u003cp\u003eThe Challenges of Pharmacogenomics for Pharmacy Education, Practice, and Regulation  (D. Brushwood).\u003c\/p\u003e \u003cp\u003ePART IV: THE SOCIAL DIMENSION.\u003c\/p\u003e \u003cp\u003eEconomic Implications of Pharmacogenomics (C. Reeder \u0026amp; W. Dickson). \u003c\/p\u003e \u003cp\u003e Pharmacogenomics and the Social Construction of Identity (M. Foster).\u003c\/p\u003e \u003cp\u003ePharmacogenomics: Considerations for Communities of Color (L. Nsiah-Jefferson).\u003c\/p\u003e \u003cp\u003eConstitutional Issues in the Use of Pharmacogenomic Variations Associated with Race (J. Robertson).\u003c\/p\u003e \u003cp\u003ePART V: EPILOGUE: POLICY PRESCRIPTIONS (M. Rothstein).\u003c\/p\u003e \u003cp\u003ePharmacogenomics and Minority Populations: General Population Survey Questionnaire (M. Rothstein).\u003c\/p\u003e \u003cp\u003eIndex.\u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Biology, life sciences [\u003ca title=\"See our other books on Biology, life sciences\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Biology,%20life%20sciences%20%5BPS%5D%22\"\u003ePS\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Wiley-Liss","offers":[{"title":"Brand New","offer_id":52286321918232,"sku":"9780471227694","price":79.88,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/files\/9780471227694.jpg?v=1781549878","url":"https:\/\/freshlyprintedbooks.co.uk\/products\/pharmacogenomics-social-ethical-and-clinical-dimensions-hardback-9780471227694","provider":"Freshly Printed Books","version":"1.0","type":"link"}